Emergent sells once troubled Baltimore site to Syngene
Emergent is selling a manufacturing site in Baltimore — which has a history of contaminated Covid-19 vaccines — for $36.5 million to India-headquartered CDMO Syngene. The facility in the Bayview neighborhood hasn't been operational for at least ...
Emergent is selling a manufacturing site in Baltimore — which has a history of contaminated Covid-19 vaccines — for $36.5 million to India-headquartered CDMO Syngene.
The facility in the Bayview neighborhood hasn't been operational for at least ...
